Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.

J Transl Med 2016 07 1;14(1):196. Epub 2016 Jul 1.

Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland.

Background: Colorectal cancer (CRC) is a leading cause of cancer mortality in the Western world and commonly treated with genotoxic chemotherapy. Stress in the endoplasmic reticulum (ER) was implicated to contribute to chemotherapeutic resistance. Hence, ER stress related protein may be of prognostic or therapeutic significance.

Methods: The expression levels of ER stress proteins calnexin, calreticulin, GRP78 and GRP94 were determined in n = 23 Stage II and III colon cancer fresh frozen tumour and matched normal tissue samples. Data were validated in a cohort of n = 11 rectal cancer patients treated with radiochemotherapy in the neoadjuvant setting. The calnexin gene was silenced using siRNA in HCT116 cells.

Results: There were no increased levels of ER stress proteins in tumour compared to matched normal tissue samples in Stage II or III CRC. However, increased calnexin protein levels were predictive of poor clinical outcome in the patient cohort. Data were validated in the rectal cancer cohort treated in the neoadjuvant setting. Calnexin gene-silencing significantly reduced cell survival and increased cancer cell susceptibility to 5FU chemotherapy.

Conclusion: Increased tumour protein levels of calnexin may be of prognostic significance in CRC, and calnexin may represent a potential target for future therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-0948-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930591PMC
July 2016
34 Reads

Publication Analysis

Top Keywords

neoadjuvant setting
8
rectal cancer
8
protein levels
8
data validated
8
stage iii
8
colorectal cancer
8
tissue samples
8
setting calnexin
8
levels stress
8
matched normal
8
stress proteins
8
protein prognostic
8
normal tissue
8
cancer
7
calnexin
7
colon cancer
4
patient cohort
4
cancer fresh
4
fresh frozen
4
clinical outcome
4

References

(Supplied by CrossRef)

SY Yang et al.
Trends Mol Med 2009

A Figueredo et al.
Cochrane Database Syst Rev 2008

P Ragnhammar et al.
Acta Oncol 2001

R Gray et al.
Lancet 2007

A Gramont de et al.
J Clin Oncol 2000

G Wang et al.
Am J Transl Res. 2010

M Ni et al.
FEBS Lett 2007

DE Feldman et al.
Mol Cancer Res 2005

M Corazzari et al.
Cell Death Differ 2015

AH Schonthal et al.
Cancer Lett 2009

X Li et al.
J Hematol Oncol 2011

Similar Publications